Citius Oncology Prices Public Offering at $1.32 a Share

MT Newswires Live

2025/07/16

Citius Oncology (CTOR) said Wednesday that it priced its "reasonable best-efforts" public offering of about 6.8 million common shares and warrants to purchase common shares at $1.32 per share, for total proceeds of about $9 million.

The company said the warrants are immediately exercisable for $1.32 per share and will expire five years from issuance.

Citius said net proceeds will be used to support the commercialization of Lymphir and for general corporate purposes. The offering is expected to close on or about Thursday, the company said.

Shares of Citius Oncology were down more than 7% in early Wednesday trading.

Price: 1.42, Change: -0.12, Percent Change: -7.79

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2551312514"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2551312514\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2551312514?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-16 21:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551312514","market":"us","top_or_hot":-1,"title":"Citius Oncology Prices Public Offering at $1.32 a Share","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/CTOR\">Citius Oncology</a> (CTOR) said Wednesday that it priced its \"reasonable best-efforts\" public offering of about 6.8 million common shares and warrants to purchase common shares at $1.32 per share, for total proceeds of about $9 million.</p><p>The company said the warrants are immediately exercisable for $1.32 per share and will expire five years from issuance.</p><p>Citius said net proceeds will be used to support the commercialization of Lymphir and for general corporate purposes. The offering is expected to close on or about Thursday, the company said.</p><p>Shares of Citius Oncology were down more than 7% in early Wednesday trading.</p><p>Price: 1.42, Change: -0.12, Percent Change: -7.79</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Citius Oncology Prices Public Offering at $1.32 a Share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCitius Oncology Prices Public Offering at $1.32 a Share\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-07-16 21:45</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/CTOR\">Citius Oncology</a> (CTOR) said Wednesday that it priced its \"reasonable best-efforts\" public offering of about 6.8 million common shares and warrants to purchase common shares at $1.32 per share, for total proceeds of about $9 million.</p><p>The company said the warrants are immediately exercisable for $1.32 per share and will expire five years from issuance.</p><p>Citius said net proceeds will be used to support the commercialization of Lymphir and for general corporate purposes. The offering is expected to close on or about Thursday, the company said.</p><p>Shares of Citius Oncology were down more than 7% in early Wednesday trading.</p><p>Price: 1.42, Change: -0.12, Percent Change: -7.79</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CTOR","symbol_name":"CITIUS ONCOLOGY INC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2551312514","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2551312514","pubTimestamp":1752673532,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Citius Oncology  said Wednesday that it priced its \"reasonable best-efforts\" public offering of about 6.8 million common shares and warrants to purchase common shares at $1.32 per share, for total proceeds of about $9 million.The company said the warrants are immediately exercisable for $1.32 per share and will expire five years from issuance.Citius said net proceeds will be used to support the commercialization of Lymphir and for general corporate purposes. The offering is expected to close on or about Thursday, the company said.Shares of Citius Oncology were down more than 7% in early Wednesday trading.Price: 1.42, Change: -0.12, Percent Change: -7.79","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CTOR":"CITIUS ONCOLOGY INC","BK4139":"生物科技"},"translate_title":"Citius Oncology公开发行定价为每股1.32美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTOR":0.9},"content_text":"Citius Oncology (CTOR) said Wednesday that it priced its \"reasonable best-efforts\" public offering of about 6.8 million common shares and warrants to purchase common shares at $1.32 per share, for total proceeds of about $9 million.The company said the warrants are immediately exercisable for $1.32 per share and will expire five years from issuance.Citius said net proceeds will be used to support the commercialization of Lymphir and for general corporate purposes. The offering is expected to close on or about Thursday, the company said.Shares of Citius Oncology were down more than 7% in early Wednesday trading.Price: 1.42, Change: -0.12, Percent Change: -7.79","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}